Use access key #2 to skip to page content.
$3.38 -0.02 (-0.59%)
8/29/2008 4:00 PM

Ligand Pharmaceuticals, Inc. (LGND)

CAPS Rating:
**

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

View All Commentary (LGND)

Recs

0

Avatar jurkovich (< 20) Submitted: 5/28/08 2:18 PM : Underperform Start Price: $2.27 LGND Score: -61.32

They just had their top drug flushed by the FDA advisory committee. They have nothing going for them.

Report this Post Replies: 0 | Reply

Featured Broker Partners